Literature DB >> 18785909

Lymphocyte subset reconstitution patterns in children with small bowel transplantation induced with steroid-free rabbit anti-human thymocyte globulin.

Anjan J Talukdar1, Chethan Ashokkumar, Patrick Wilson, Ankit Gupta, Qing Sun, Linda Boig, Kareem Abu-Elmagd, George Mazariegos, Michael Green, Rakesh Sindhi.   

Abstract

Multiple measurements (n = 212) of lymphocyte subsets in 67 children treated with steroid-free Tacrolimus, and rabbit anti-human thymocyte globulin induction demonstrate early reconstitution of T-cytotoxic and NK cells. Reconstitution of CD4+ cells is complete after the second post-transplant year. During the period at risk for rejection, NK and T-cytotoxic cell counts are significantly higher among Rejectors. During periods at increased risk for EBV viral infection, CD4 counts bear a significant inverse relationship to EBV viral load in a subset of at-risk recipients. Rejection-prone children also demonstrate significantly higher counts of total lymphocytes, Tc and NK cells prior to SBTx, and may illustrate one basis for enhanced baseline immunocompetence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785909     DOI: 10.1111/j.1399-3046.2008.01010.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

1.  Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection.

Authors:  Chethan Ashokkumar; Mylarappa Ningappa; Sarangarajan Ranganathan; Brandon W Higgs; Qing Sun; Lori Schmitt; Sara Snyder; Jennifer Dobberstein; Maria Branca; Ronald Jaffe; Adriana Zeevi; Robert Squires; Feras Alissa; Benjamin Shneider; Kyle Soltys; Geoffrey Bond; Kareem Abu-Elmagd; Abhinav Humar; George Mazariegos; Hakon Hakonarson; Rakesh Sindhi
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

2.  Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.

Authors:  Chethan Ashokkumar; Qing Sun; Mylarappa Ningappa; Brandon W Higgs; George Mazariegos; Adriana Zeevi; Rakesh Sindhi
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

3.  Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens.

Authors:  Chethan Ashokkumar; Bishu Ganguly; Robert Townsend; Jaimie White; Samantha Levy; Michael Moritz; George Mazariegos; Qing Sun; Rakesh Sindhi
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.